BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9586892)

  • 1. Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial.
    Riethmüller G; Holz E; Schlimok G; Schmiegel W; Raab R; Höffken K; Gruber R; Funke I; Pichlmaier H; Hirche H; Buggisch P; Witte J; Pichlmayr R
    J Clin Oncol; 1998 May; 16(5):1788-94. PubMed ID: 9586892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group.
    Riethmüller G; Schneider-Gädicke E; Schlimok G; Schmiegel W; Raab R; Höffken K; Gruber R; Pichlmaier H; Hirche H; Pichlmayr R
    Lancet; 1994 May; 343(8907):1177-83. PubMed ID: 7909866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):2935-8. PubMed ID: 9329568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
    Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
    Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of the number of metastatic lymph nodes in dukes' C colorectal cancer.
    Fukushima T; Akagi Y; Murakami H; Ushijima M; Ogata Y; Shirouzu K; Murotani K
    Anticancer Res; 2013 Jul; 33(7):2949-55. PubMed ID: 23780985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors predictive of survival in patients with node-positive colorectal cancer in Taiwan.
    Wang WS; Chen PM; Chiou TJ; Liu JH; Fan FS; Lin TC; Jiang JK; Yang SH; Yen CC; Wang HS; Lin JK
    Hepatogastroenterology; 2000; 47(36):1590-4. PubMed ID: 11149009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma.
    Diez M; Cerdán FJ; Pollán M; Maestro ML; Ortega MD; Martínez S; Moreno G; Balibrea JL
    Anticancer Res; 1994; 14(6B):2819-25. PubMed ID: 7872725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
    Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
    Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients.
    Mulder WM; Stern PL; Stukart MJ; de Windt E; Butzelaar RM; Meijer S; Adér HJ; Claessen AM; Vermorken JB; Meijer CJ; Wagstaff J; Scheper RJ; Bloemena E
    Clin Cancer Res; 1997 Nov; 3(11):1923-30. PubMed ID: 9815581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative serum alpha-L-fucosidase activity as a prognostic marker in colorectal cancer.
    Ayude D; Páez De La Cadena M; Martínez-Zorzano VS; Fernández-Briera A; Rodríguez-Berrocal FJ
    Oncology; 2003; 64(1):36-45. PubMed ID: 12457030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
    Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
    Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
    Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
    Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site and Stage of Colorectal Cancer Influence the Likelihood and Distribution of Disease Recurrence and Postrecurrence Survival: Data From the FACS Randomized Controlled Trial.
    Pugh SA; Shinkins B; Fuller A; Mellor J; Mant D; Primrose JN
    Ann Surg; 2016 Jun; 263(6):1143-7. PubMed ID: 26135689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer.
    Miyamoto Y; Baba Y; Sakamoto Y; Ohuchi M; Tokunaga R; Kurashige J; Hiyoshi Y; Iwagami S; Yoshida N; Yoshida M; Watanabe M; Baba H
    Ann Surg Oncol; 2015 Aug; 22(8):2663-8. PubMed ID: 25564158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer.
    Ropponen K; Tammi M; Parkkinen J; Eskelinen M; Tammi R; Lipponen P; Agren U; Alhava E; Kosma VM
    Cancer Res; 1998 Jan; 58(2):342-7. PubMed ID: 9443415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
    Foon KA; John WJ; Chakraborty M; Das R; Teitelbaum A; Garrison J; Kashala O; Chatterjee SK; Bhattacharya-Chatterjee M
    J Clin Oncol; 1999 Sep; 17(9):2889-5. PubMed ID: 10561367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery for lung metastases from colorectal cancer: analysis of prognostic factors.
    Girard P; Ducreux M; Baldeyrou P; Rougier P; Le Chevalier T; Bougaran J; Lasser P; Gayet B; Ruffié P; Grunenwald D
    J Clin Oncol; 1996 Jul; 14(7):2047-53. PubMed ID: 8683235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes' stage B disease.
    Evans MD; Barton K; Rees A; Stamatakis JD; Karandikar SS
    Colorectal Dis; 2008 Feb; 10(2):157-64. PubMed ID: 17477849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.